Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;4(1):e807.
doi: 10.7191/gmr.807. Epub 2024 Feb 22.

The Alcohol Flush Response

Isabel Moh  1 , Daniel Simon  2 , Eric R Gross  2
Affiliations

The Alcohol Flush Response

Isabel Moh et al. Graph Med Rev. 2024.

Abstract

Nearly 540 million people world-wide have facial flushing and an increased heart rate after consuming alcohol. Known as the alcohol flushing response, this reaction to alcohol is a result of a genetic variant in an enzyme aldehyde dehydrogenase 2 (ALDH2), known as ALDH2*2. Mainly carried by those of East Asian descent, the genetic variant is likely the most common genetic variant carried in the world. Carrying this ALDH2*2 genetic variant has important health implications with respect cancer risk which is increased when carriers of the ALDH2*2 genetic variant frequently use of alcohol or tobacco products. This comic explains the alcohol flush response and the health risks associated with alcohol and tobacco use for those who carry an ALDH2*2 variant.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The author declares that they have no competing interests.

References

    1. Brooks PJ, Enoch M-A, Goldman D, Li T-K, & Yokoyama A (2009). The alcohol flushing response: An unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Medicine, 6(3). 10.1371/journal.pmed.1000050 - DOI - PMC - PubMed
    1. Chen C-H, Ferreira JC, Gross ER, & Mochly-Rosen D (2014). Targeting aldehyde dehydrogenase 2: New therapeutic opportunities. Physiological Reviews, 94(1), 1–34. 10.1152/physrev.00017.2013 - DOI - PMC - PubMed
    1. Gross ER, Zambelli VO, Small BA, Ferreira JCB, Chen C-H, & Mochly-Rosen D (2015). A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant. Annual Review of Pharmacology and Toxicology, 55(1), 107–127. 10.1146/annurev-pharmtox-010814-124915 - DOI - PMC - PubMed
    1. Guo H, Yu X, Liu Y, Paik DT, Justesen JM, Chandy M, Jahng JWS, Zhang T, Wu W, Rwere F, Zhao SR, Pokhrel S, Shivnaraine RV, Mukherjee S, Simon DJ, Manhas A, Zhang A, Chen C-H, Rivas MA, … Wu JC (2023). SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common aldh2 alcohol flushing variant. Science Translational Medicine, 15(680). 10.1126/scitranslmed.abp9952 - DOI - PMC - PubMed
    1. Heymann HM, Gardner AM, & Gross ER (2018). Aldehyde-induced DNA and protein adducts as biomarker tools for alcohol use disorder. Trends in Molecular Medicine, 24(2), 144–155. 10.1016/j.molmed.2017.12.003 - DOI - PMC - PubMed